ARTICLE | Clinical News
Repatha evolocumab: Phase III data
October 10, 2016 7:00 AM UTC
Top-line data from the double-blind, international Phase III GLAGOV trial in 968 CAD patients receiving optimized statin therapy and undergoing coronary catheterization showed that once-monthly 420 mg...